Novel splice variants of the human kallikrein-related peptidases 11 (KLK11) and 12 (KLK12), unraveled by next-generation sequencing technology

References

Adamopoulos, P.G., Kontos, C.K., and Scorilas, A. (2017a). Identification and molecular cloning of novel transcripts of the human kallikrein-related peptidase 10 (KLK10) gene using next-generation sequencing. Biochem. Biophys. Res. Commun. 487, 776–781.10.1016/j.bbrc.2017.04.078Search in Google Scholar PubMed

Adamopoulos, P.G., Kontos, C.K., and Scorilas, A. (2017b). Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using next-generation sequencing. Sci. Rep. 7, 17299.10.1038/s41598-017-16269-6Search in Google Scholar PubMed PubMed Central

Alexopoulou, D.K., Kontos, C.K., Christodoulou, S., Papadopoulos, I.N., and Scorilas, A. (2014). KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. Biomark. Med. 8, 671–685.10.2217/bmm.13.151Search in Google Scholar PubMed

Avgeris, M. and Scorilas, A. (2016). Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. Expert Opin. Ther. Targets 20, 801–818.10.1517/14728222.2016.1147560Search in Google Scholar PubMed

Avgeris, M., Mavridis, K., and Scorilas, A. (2010). Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies. Biol. Chem. 391, 505–511.10.1515/bc.2010.056Search in Google Scholar PubMed

Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876–890.10.1038/nrc1474Search in Google Scholar PubMed

Clark, H.F., Gurney, A.L., Abaya, E., Baker, K., Baldwin, D., Brush, J., Chen, J., Chow, B., Chui, C., Crowley, C., et al. (2003). The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13, 2265–2270.10.1101/gr.1293003Search in Google Scholar PubMed PubMed Central

Geng, X., Liu, Y., Diersch, S., Kotzsch, M., Grill, S., Weichert, W., Kiechle, M., Magdolen, V., and Dorn, J. (2017). Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer. PLoS One 12, e0186847.10.1371/journal.pone.0186847Search in Google Scholar PubMed PubMed Central

Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1–14.10.1016/j.bbcan.2005.02.001Search in Google Scholar PubMed

Planque, C., Choi, Y.H., Guyetant, S., Heuze-Vourc’h, N., Briollais, L., and Courty, Y. (2010). Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer. Clin. Chem. 56, 987–997.10.1373/clinchem.2009.138917Search in Google Scholar PubMed

Sano, A., Sangai, T., Maeda, H., Nakamura, M., Hasebe, T., and Ochiai, A. (2007). Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3. Int. J. Oncol. 30, 1493–1498.10.3892/ijo.30.6.1493Search in Google Scholar

Shaw, J.L. and Diamandis, E.P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423–1432.10.1373/clinchem.2007.088104Search in Google Scholar PubMed

Talieri, M., Devetzi, M., Scorilas, A., Pappa, E., Tsapralis, N., Missitzis, I., and Ardavanis, A. (2012). Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact. Tumour Biol. 33, 1075–1084.10.1007/s13277-012-0347-xSearch in Google Scholar PubMed

Venables, J.P. (2006). Unbalanced alternative splicing and its significance in cancer. Bioessays 28, 378–386.10.1002/bies.20390Search in Google Scholar PubMed

Wen, Y.G., Wang, Q., Zhou, C.Z., Yan, D.W., Qiu, G.Q., Yang, C., Tang, H.M., and Peng, Z.H. (2011). Identification and validation of kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. J. Surg. Oncol. 104, 516–524.10.1002/jso.21981Search in Google Scholar PubMed

Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., Kogot, J.M., Scarisbrick, I.A., and Blaber, M. (2007). Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852–31864.10.1074/jbc.M705190200Search in Google Scholar PubMed

Yoshida, S., Taniguchi, M., Suemoto, T., Oka, T., He, X., and Shiosaka, S. (1998). cDNA cloning and expression of a novel serine protease, TLSP. Biochim. Biophys. Acta 1399, 225–228.10.1016/S0167-4781(98)00116-XSearch in Google Scholar

Yousef, G.M., Chang, A., Scorilas, A., and Diamandis, E.P. (2000a). Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125–133.10.1006/bbrc.2000.3448Search in Google Scholar PubMed

Yousef, G.M., Magklara, A., and Diamandis, E.P. (2000b). KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer. Genomics 69, 331–341.10.1006/geno.2000.6346Search in Google Scholar PubMed

Zhang, J., Sun, X., Qian, Y., and Maquat, L.E. (1998). Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm. RNA 4, 801–815.10.1017/S1355838298971849Search in Google Scholar PubMed PubMed Central